Nautilus Biotechnology NAUT reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM.
Here’s what investors need to know about the announcement.
Nautilus Biotechnology beat estimated earnings by 29.41%, reporting an EPS of $-0.12 versus an estimate of $-0.17.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 0.63% drop in the share price the next day.
To track all earnings releases for Nautilus Biotechnology visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Image and article originally from www.benzinga.com. Read the original article here.